|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
CA1331443C
(en)
|
1987-05-29 |
1994-08-16 |
Charlotte A. Kensil |
Saponin adjuvant
|
|
GB8911525D0
(en)
|
1989-05-19 |
1989-07-05 |
Allied Colloids Ltd |
Polymeric composition
|
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
US5766846A
(en)
|
1992-07-10 |
1998-06-16 |
Athena Neurosciences |
Methods of screening for compounds which inhibit soluble β-amyloid peptide production
|
|
US5562909A
(en)
|
1993-07-12 |
1996-10-08 |
Massachusetts Institute Of Technology |
Phosphazene polyelectrolytes as immunoadjuvants
|
|
AU7642494A
(en)
|
1993-08-31 |
1995-03-22 |
Gliatech Inc. |
Inhibition of beta amyloid binding to glycosaminoglycans for treatment of alzheimer's disease
|
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
|
US20030072774A1
(en)
|
1994-06-10 |
2003-04-17 |
Diane M. Gajewczyk |
Proteinaceous adjuvants
|
|
US6019982A
(en)
|
1994-08-26 |
2000-02-01 |
The Administrators Of The Tulane Educational Fund |
Mutant enterotoxin effective as a non-toxic oral adjuvant
|
|
FR2726764B1
(fr)
|
1994-11-14 |
1997-01-31 |
Pasteur Merieux Serums Vacc |
Adjuvant pour composition vaccinale
|
|
WO1996028471A1
(en)
|
1995-03-14 |
1996-09-19 |
Praecis Pharmaceuticals Incorporated |
Modulators of amyloid aggregation
|
|
AU1072897A
(en)
*
|
1995-12-12 |
1997-07-03 |
Karolinska Innovations Ab |
Peptide binding the klvff-sequence of amyloid beta
|
|
US5735814A
(en)
|
1996-04-30 |
1998-04-07 |
Medtronic, Inc. |
Techniques of treating neurodegenerative disorders by brain infusion
|
|
US6071493A
(en)
*
|
1996-09-20 |
2000-06-06 |
Baylor College Of Medicine |
Method of screening for an agent that inhibits mononuclear phagocyte-plaque component complex formation
|
|
US6043283A
(en)
*
|
1996-09-20 |
2000-03-28 |
Baylor College Of Medicine |
Tyramine compounds and their neuronal effects
|
|
NZ333334A
(en)
|
1997-04-17 |
2001-06-29 |
Frank L Sorgi |
Delivery system for gene therapy to the brain
|
|
US7790856B2
(en)
*
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7964192B1
(en)
*
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US6761888B1
(en)
*
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7179892B2
(en)
*
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6923964B1
(en)
*
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
|
US6913745B1
(en)
*
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
|
US7588766B1
(en)
*
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
|
US7012061B1
(en)
|
1998-10-19 |
2006-03-14 |
New York University |
Method for increasing the permeability of the blood brain barrier
|
|
IL146009A0
(en)
*
|
1999-05-05 |
2002-07-25 |
Neurochem Inc |
Stereoselective antifibrillogenic peptides and peptidomimetics thereof
|
|
UA81216C2
(en)
*
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
|
MXPA02005576A
(es)
|
1999-11-29 |
2002-12-13 |
Neurochem Inc |
Vacuna para la prevencion y tratamiento de la enfermedad de alzheimer y otras enfermedades relacionadas con amiloides.
|
|
SI1481992T1
(sl)
*
|
2000-02-24 |
2017-01-31 |
Washington University St. Louis |
Humanizirana protitelesa, ki vežejo amiloidni peptid beta
|
|
US6686443B1
(en)
|
2000-05-26 |
2004-02-03 |
The Regents Of The University Of California |
Chemical reagents for formation of disulfide bonds in peptides
|
|
EP1309341A2
(en)
*
|
2000-07-07 |
2003-05-14 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
AU2007234495A1
(en)
*
|
2000-09-08 |
2007-12-06 |
Board Of Regents, The University Of Texas System |
Biopanning and rapid analysis of selective interactive ligands (BRASIL)
|
|
TWI255272B
(en)
*
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7700751B2
(en)
*
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
JP2005501220A
(ja)
|
2000-12-19 |
2005-01-13 |
パラチン テクノロジーズ インク． |
ペプチドおよび蛋白質の標的特異的折りたたみ部位の識別
|
|
DE10101430B4
(de)
|
2001-01-13 |
2008-10-02 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Lösliche cyclische Analoga zur Modulation der Amyloidogenese
|
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP1523499A2
(en)
*
|
2002-07-24 |
2005-04-20 |
Innogenetics N.V. |
Fragments of beta-amyloid as targets for vaccination against alzheimer disease
|
|
US9535076B2
(en)
|
2002-09-12 |
2017-01-03 |
The Regents Of The University Of California |
Methods and compositions for eliciting an amyloid-selective immune response
|
|
WO2004029629A1
(en)
|
2002-09-27 |
2004-04-08 |
Janssen Pharmaceutica N.V. |
N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
|
|
EP1581203A1
(en)
|
2002-12-24 |
2005-10-05 |
Neurochem (International) Limited |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
US7575747B2
(en)
|
2003-02-10 |
2009-08-18 |
Applied Molecular Evolution |
Aβ binding molecules
|
|
DE04759123T1
(de)
|
2003-04-07 |
2005-08-18 |
Novetide Ltd. |
Verfahren zur herstellung cyclischer peptide
|
|
TWI306458B
(en)
*
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP1484336A1
(en)
|
2003-06-02 |
2004-12-08 |
Pevion Biotech Ltd. |
Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
|
|
JP2007527865A
(ja)
|
2003-09-12 |
2007-10-04 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
種々の配列を有するタンパク質から形成されたアミロイドに共通の高分子量凝集中間体に特異的なモノクローナル抗体
|
|
CN1562050A
(zh)
|
2004-03-24 |
2005-01-12 |
中国海洋大学 |
褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
|
|
US20050267029A1
(en)
*
|
2004-04-02 |
2005-12-01 |
Ancsin John B |
Compounds which modulate amyloidogenesis and methods for their identification and use
|
|
US20060129126A1
(en)
|
2004-11-19 |
2006-06-15 |
Kaplitt Michael G |
Infusion device and method for infusing material into the brain of a patient
|
|
EP1838348B1
(en)
|
2004-12-15 |
2013-06-26 |
Janssen Alzheimer Immunotherapy |
Humanized amyloid beta antibodies for use in improving cognition
|
|
ES2396555T3
(es)
*
|
2004-12-15 |
2013-02-22 |
Janssen Alzheimer Immunotherapy |
Anticuerpos que reconocen péptido beta amiloide
|
|
EP1676859A1
(en)
*
|
2004-12-30 |
2006-07-05 |
Pevion Biotech Ltd. |
Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide
|
|
ES2259270B1
(es)
|
2005-03-09 |
2007-11-01 |
Consejo Superior De Investigaciones Cientificas |
Metodo de diagnostico in vitro de la enfermedad de alzheimer mediante un anticuerpo monoclonal.
|
|
CA2609980C
(en)
|
2005-05-27 |
2015-10-13 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
WO2007059000A2
(en)
*
|
2005-11-10 |
2007-05-24 |
Roskamp Research, Llc |
Modulation of angiogenesis by a-beta peptide fragments
|
|
ATE517923T1
(de)
|
2005-12-12 |
2011-08-15 |
Hoffmann La Roche |
Antikörper gegen amyloid beta mit glykosilierung in der variablen region
|
|
AU2007223427A1
(en)
|
2006-03-01 |
2007-09-13 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
US8784810B2
(en)
*
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
SG173385A1
(en)
|
2006-07-14 |
2011-08-29 |
Ac Immune S A Ch |
Humanized antibody against amyloid beta
|
|
DK2074145T5
(en)
|
2006-10-02 |
2017-10-16 |
Ac Immune Sa |
HUMANIZED ANTIBODY AGAINST AMYLOID BETA
|
|
EP2842967B1
(en)
|
2007-01-18 |
2016-11-30 |
Eli Lilly and Company |
Pegylated amyloid beta fab
|
|
US8003097B2
(en)
*
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
BRPI0812484A2
(pt)
|
2007-06-12 |
2018-06-05 |
Ac Immune Sa |
anticorpo monoclonal, regiões variáveis de cadeia leve e de cadeia pesada, cdr isolada, polinucleotídeo, composição terapêutica, métodos para tratar doenças e distúrbios, para produzir um anticorpo, para tratar ou aliviar os efeitos de doenças e distúrbios, para reduzir a carga de placas no cérebro de um indivíduo, para reduzir a quantidade de placas no cérebro de um indivíduo, para diminuir a quantidade total de abeta solúvel no cérebro de um indivíduo, para reter ou aumentar a capacidade de memória cognitiva em um indivíduo, de diagnose de ou para diagnosticar uma predisposição para uma doença associada com amilóide ou condição em um paciente, para determinar a extensão de carga de placa amiloidogênica em um tecido de um indivíduo, para monitorar doença residual mínima em um indivíduo e para prever responsividade de um indivíduo, linhagem de células, kit de teste, epítopo abeta
|
|
US20090155249A1
(en)
|
2007-06-12 |
2009-06-18 |
Ac Immune S.A. |
Humanized antibody igg1
|
|
DK2182983T3
(da)
*
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
|
NZ585110A
(en)
|
2007-10-05 |
2012-09-28 |
Genentech Inc |
Method and compositions for diagnosis and treatment of amyloidosis
|
|
EP2650308A3
(en)
|
2007-10-05 |
2014-11-12 |
Genentech, Inc. |
Use of anti-amyloid beta antibody in ocular diseases
|
|
US20090246191A1
(en)
|
2007-10-11 |
2009-10-01 |
University Of Tennessee Research Foundation |
Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
KR20100097651A
(ko)
|
2007-10-29 |
2010-09-03 |
인썸 |
베타-아밀로이드 펩티드에 특이적인 신규 항체 및 진단제 또는 진단약으로서의 그 용도
|
|
PT2207568T
(pt)
|
2007-11-16 |
2017-09-01 |
Univ Rockefeller |
Anticorpos específicos para a forma de protofibrilha da proteína beta-amilóide
|
|
DK2237803T3
(en)
|
2007-12-28 |
2015-10-05 |
Prothena Biosciences Ltd |
Treatment and prophylaxis of amyloidosis
|
|
WO2009143489A2
(en)
*
|
2008-05-22 |
2009-11-26 |
Archer Pharmaceuticals, Inc. |
Modulation of angiogenesis by a-beta peptide fragments
|
|
AT506819B1
(de)
|
2008-06-12 |
2011-06-15 |
Affiris Forschungs Und Entwicklungs Gmbh |
Vakzin zur behandlung von alzheimer-krankheit
|
|
JP2011522842A
(ja)
|
2008-06-12 |
2011-08-04 |
アフィリス・アクチェンゲゼルシャフト |
パーキンソン病に関連する症状の治療のための化合物
|
|
AT509611B1
(de)
|
2008-06-12 |
2012-04-15 |
Affiris Forschungs-Und Entwicklungs Gmbh |
Vakzin
|
|
RU2546234C2
(ru)
*
|
2008-07-01 |
2015-04-10 |
Де Стат Дер Недерланден, Верт.Дор Де Министер Ван Ввс |
Вакцина против интермедиата с амилоидным сворачиванием
|
|
US9801865B2
(en)
|
2008-09-24 |
2017-10-31 |
The United States Of America As Represented By The Department Of Veteran Affairs |
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
|
|
EP2172485A1
(en)
|
2008-10-01 |
2010-04-07 |
Pierre Fabre Medicament |
Novel anti CXCR4 antibodies and their use for the treatment of cancer
|
|
EP2342220B1
(en)
|
2008-10-06 |
2021-05-12 |
The University Of British Columbia |
Methods and systems for predicting misfolded protein epitopes
|
|
US9067981B1
(en)
*
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
JP5812418B2
(ja)
|
2009-04-17 |
2015-11-11 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
WO2010128139A1
(en)
|
2009-05-08 |
2010-11-11 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Biomarkers and methods for diagnosing alzheimer's disease and/ or mild cognitive impairment
|
|
CN102574915B
(zh)
|
2009-08-06 |
2014-10-22 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
JP5554528B2
(ja)
*
|
2009-09-08 |
2014-07-23 |
国立大学法人 岡山大学 |
新規アミロイドβ凝集体結合性ペプチドおよび新規アミロイドβ凝集体結合性ペプチドを用いたアミロイド病の検査方法
|
|
SG10201405802UA
(en)
|
2009-09-18 |
2014-11-27 |
Probiodrug Ag |
Novel assay for the detection of amyloid beta peptides
|
|
ES2661925T3
(es)
|
2010-02-26 |
2018-04-04 |
Bioarctic Ab |
Anticuerpos de unión a las protofibrillas y su uso en métodos terapéuticos diagnósticos para la enfermedad de Parkinson, la demencia con cuerpos de Lewy y otras alfa-sinucleinopatías
|
|
EP2542571B1
(en)
*
|
2010-03-03 |
2016-05-25 |
The University of British Columbia |
Oligomer-specific amyloid beta epitope and antibodies
|
|
EP2550529B1
(en)
*
|
2010-03-23 |
2021-11-17 |
Iogenetics, LLC. |
Bioinformatic processes for determination of peptide binding
|
|
US20110256064A1
(en)
|
2010-04-16 |
2011-10-20 |
Ac Immune, S.A. |
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
|
|
BR112012026249B1
(pt)
|
2010-04-16 |
2021-08-17 |
Ac Immune Sa |
Composto, formulação radiofarmacêutica, composição farmacêutica, uso do composto, mistura, métodos de coletar dados para o diagnóstico de uma doença ou condição associadas com amiloide, de determinar a extensão de carga amiloidogênica de placas em um tecido e/ou um fluido corporal, de coletar dados para determinar uma predisposição a uma doença ou condição associadas com amiloide em um paciente, de coletar dados para monitorar a doença residual mínima em um paciente seguindo o tratamento com um anticorpo ou uma composição de vacina, de coletar dados para predizer capacidade de reação de um paciente sendo tratado com um anticorpo ou uma composição de vacina, e, kit de teste
|
|
US9320793B2
(en)
|
2010-07-14 |
2016-04-26 |
Acumen Pharmaceuticals, Inc. |
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
|
|
MX341369B
(es)
|
2010-07-30 |
2016-08-17 |
Genentech Inc * |
Anticuerpo anti-beta-amiloide humanizado seguro y funcional.
|
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
|
CA2817973C
(en)
|
2010-10-15 |
2019-06-25 |
The Board Of Regents Of The University Of Texas System |
Antibodies that bind amyloid oligomers
|
|
FR2966827B1
(fr)
*
|
2010-10-27 |
2014-08-22 |
Kimonella Ventures Ltd |
Compose peptidique utile pour l'inhibition de la formation de plaques amyloides
|
|
US20120321694A1
(en)
*
|
2010-10-27 |
2012-12-20 |
Daniel Larocque |
Compositions and uses
|
|
WO2012104824A1
(en)
|
2011-02-04 |
2012-08-09 |
Ecole polytechnique fédérale de Lausanne (EPFL) |
Therapeutic antibodies targeting app-c99
|
|
EP2511296A1
(en)
*
|
2011-04-12 |
2012-10-17 |
Araclón Biotech, S. L. |
Antibody, kit and method for determination of amyloid peptides
|
|
GB201113570D0
(en)
*
|
2011-08-05 |
2011-09-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
CN104093454A
(zh)
*
|
2011-11-10 |
2014-10-08 |
坎格尼美国股份有限公司 |
治疗阿耳茨海默氏病的组合物和方法
|
|
EP2659908A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
|
FR2993265B1
(fr)
|
2012-07-16 |
2014-11-21 |
Saint Gobain Isover |
Dispositif de formation de fibres minerales
|
|
JP2015527369A
(ja)
|
2012-08-21 |
2015-09-17 |
インスティテュート フォー モレキュラー メディシン， インコーポレイテッド |
アミロイド、タウおよびα−シヌクレインの沈着に関連する疾患に関する組成物および方法
|
|
EP2787347A1
(en)
|
2013-04-03 |
2014-10-08 |
Affiris AG |
Method for detecting Aß-specific antibodies in a biological sample
|
|
EP3030580A4
(en)
|
2013-08-05 |
2017-04-05 |
St. Vincent's Institute Of Medical Research |
An antibody therapy for amyloid beta disease
|
|
BR112016004242A8
(pt)
|
2013-08-28 |
2018-06-12 |
Stemcentrx Inc |
Métodos para conjugação sítio-específica de anticorpos e composições
|
|
CA2938129A1
(en)
|
2014-02-03 |
2015-08-06 |
Cangene Corporation |
Humanized beta-amyloid binding molecules and uses thereof
|
|
WO2016138525A1
(en)
*
|
2015-02-27 |
2016-09-01 |
University Of Washington |
Polypeptide assemblies and methods for the production thereof
|
|
US20170021020A1
(en)
|
2015-07-23 |
2017-01-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Monoclonal antibody and vaccine targeting filamentous bacteriophage
|
|
RS59688B1
(sr)
|
2015-08-11 |
2020-01-31 |
Novartis Ag |
5-bromo-2,6-di-(1h-pirazol-1-il)pirimidin-4-amin za upotrebu pri lečenju raka
|
|
WO2017066349A1
(en)
*
|
2015-10-13 |
2017-04-20 |
Symic Ip, Llc |
Ve-cadherin binding bioconjugate
|
|
CA3004498A1
(en)
*
|
2015-11-09 |
2017-05-18 |
Neil R. Cashman |
Amyloid beta epitopes and antibodies thereto
|
|
US20180326027A1
(en)
|
2015-11-09 |
2018-11-15 |
The University Of British Columbia |
Epitopes in amyloid beta and conformationally-selective antibodies thereto
|
|
WO2017079832A1
(en)
|
2015-11-09 |
2017-05-18 |
The University Of British Columbia |
C-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
|
|
JP7448174B2
(ja)
|
2015-11-09 |
2024-03-12 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
アミロイドベータ中間領域エピトープおよびそれに対する立体配座選択的抗体
|
|
US11756650B2
(en)
*
|
2015-11-09 |
2023-09-12 |
The University Of British Columbia |
Systems and methods for predicting misfolded protein epitopes by collective coordinate biasing
|
|
EP3374379A4
(en)
|
2015-11-09 |
2019-05-15 |
The University Of British Columbia |
N-TERMINAL EPITOPES IN AMYLOID BETA AND CONFORMATION-SELECTIVE ANTIBODIES
|
|
KR102550991B1
(ko)
|
2016-07-18 |
2023-07-04 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타에 대한 항체
|
|
US20180125920A1
(en)
*
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|